
Carcinoma of the bladder, which is also known as transitional cell carcinoma, affects the urothelial cells that line the urinary tract- the bladder, the ureters, and a portion of the kidneys. Thus, it becomes the form most commonly associated with the bladder; however, it may also affect other urinary system structures.
Risk Factors:
The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.
The medical treatment for Urothelial Carcinoma requires evaluating the patient's severity and medical condition. The following are the treatment options:
Transurethral Resection of Bladder Tumor (TURBT): minimally invasive surgery for surgically removing superficial tumours from the bladder.
Chemotherapy : It is intravesical for superficial tumours, while systemic (e.g., Gemcitabine and cisplatin) for tumours that have grown into muscle or metastasised.
Cost Start From USD 600 - USD 700Explore Options
Immunotherapy : Checkpoint inhibitors stimulate the immune system to attack cancer cells and are used mainly in advanced or resistant cases to chemotherapy.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation Therapy: Advanced palliative care based on external beam radiation can involve using this radiation either alone or following surgery. The advanced disease can also be treated because symptoms such as bleeding and obstruction require palliative care.
Targeted Therapy and BCG: Targeted medications that aim at specific genetic mutations. However, BCG activates the immune system against non-muscle-invasive bladder cancer, improving outcomes.
Cost Start From USD 8000 - USD 12000Explore Options
These are the standard diagnostic methods for diagnosing Urothelial Carcinoma:
MediRehab (chain of Rehab centres - part of MediGence provides comprehensive rehabilitation services designed to support patients in India. Additional services are as per the patient's requirement. These services include:









Hyderabad, India
Srikara Group of Hospitals is an 850-Bedded Tertiary Care healthcare facility, spread over 7 branches and two states in Southern India. 6 out of these 7 branches are situated in the twin city of Hyderabad- Secunderabad and 1 branch is at Vijayawada, Andhra Pradesh. As the ultimate combination of benefits a hospital can provide, Srikara Ortho & Multi-Specialty Hospitals represents the infusion of quality, knowledge, technical proficiency, international standards, compassion, and reasonably priced care. Srikara Hospital is known for its excellence in Orthopedic as well as Neuro-Spine Surgeries. With top-of-the-chart technical proficiency, quality, and skills; Srikara is the destination of choice for patients from not only India but across the globe. Srikara Hospitals are the pioneers in doing Robotics-assisted Joint Replacements in Southern India. These hospitals have been using technologies like Computer Navigation and I-Suite theaters since their inception. Three of its 7 branches offer minimally Invasive Spine surgeries done with the use of top quality Operating microscopes. For patients from other countries seeking treatment at its facilities, Srikara has established a separate unit. By partnering with hospitals and institutions that share its commitment to and passion for ‘Patient Care’, it now hopes to expand its surgical expertise throughout the country and the world.
International quality care at affordable prices is what the Srikara Group of Hospitals strives for. The quality & compassion in care can be bought in only by the human skills behind world-class technology. Rich in human skills & experience, the team of doctors at Srikara Hospitals is decorated with a collective experience of more than 23000 Knee Replacement Surgeries over a period of two decades. 5000+ of these Knee Replacements were Robotic-assisted Knee Replacement surgeries. The team of surgeons and the Sports Medicine Unit at SRIKARA Group of Hospitals hold experience in doing more than 5500 Knee Ligament surgeries. The team of Neuro-spine surgeons holds a collective experience of 11+ years and offers various surgical remedies with and without the assistance of an Operating Microscope. Srikara Group of Hospitals offers a wide array of specialties like Orthopaedics, Neuro-spine, Urology, Laparoscopy, Cardiology, Cosmetic Surgery, etc. with the help of nationally and internationally acclaimed doctors.
To expand their healthcare services globally and for the ease of their patients, the doctors at Srikara Group of Hospitals are also providing Online Consultations to individuals who are unable to visit in person but are in need of medical attention. Srikara Group of Hospitals looks forward to continuing to cater to its domestic as well as overseas patients with compassion and evidence-based healthcare services. All the hospitals of Srikara Group are built in accordance to provide relaxing, serene surroundings, greenery, and a hygienic setting to the patients & visitors. With a large influx of people seeking the best care and facilities in Hyderabad, it is well renowned for its dedication to providing unique and evidence-based healthcare services.

Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.

Hyderabad, India
Apollo Hospitals located in Hyderabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the much-growing reasons for India being frequented for Urothelial Carcinoma treatment:
Although one cannot prevent the disease, risk factor reduction- for example, quitting smoking, eating good food, staying hydrated, and avoiding chemicals can reduce the possibility of urothelial carcinoma development.
The prognosis is determined by the stage at which the cancer was diagnosed. Late-stage tumours are considered aggressive and associated with a poor prognosis, while early-stage non-muscle-invasive bladder cancer is associated with a reasonable survival rate.
PCPs and immune checkpoint inhibitors support a patient's immune system in recognising and destroying cancer cells in advanced or metastatic urothelial carcinoma cases.
Yes, urothelial carcinoma can recur, particularly in the setting of non-muscle invasive cancers. Follow-up through cystoscopies and urine tests can help detect recurrences as early as possible.
The side effects may change from treatment to treatment. They include fatigue, nausea, hair loss, urinary problems, infections, and immune-mediated side effects (in the case of immunotherapy). Managing side effects is the most critical part of the treatment journey.
Bladder cancer, specifically urothelial carcinoma, is relatively common in India, and there is an increasing incidence mainly because of clearly defined risk factors such as smoking and exposure to environmental toxins. It's among the commonly recorded malignancies of the urinary tract in India.
The probability of survival of patients with urothelial carcinoma correlates with the stage of cancer at diagnosis. Early recognition significantly augments the chances of survival, especially concerning non-muscle invasive bladder cancer. At the same time, advanced stages may confer a lesser survival probability because of being detected late and getting access to advanced treatment facilities in some regions.
In India, it is more common in men than in women. Men aged 50 years and above, especially those with a history of smoking and occupational exposure to chemicals, are at greater risk. However, bladder cancer in women is also on the rise.
Treatment is usually stage-dependent but may vary somewhat based on tumour location. Surgery, chemotherapy, immunotherapy, and sometimes radiation are often used in combinations. These combinations may enhance response to treatment, particularly amongst the advanced cases.

Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026